• IP3R/Ca2+/STAT3 Axis in Nanoplastic–Cadmium Intestinal Toxic

  2026-06-15

  This study reveals how co-exposure to polystyrene nanoplastics and cadmium synergistically induces intestinal cell apoptosis by activating the IP3R/Ca2+/STAT3 pathway. The findings advance mechanistic understanding of environmental toxicant interactions and identify calcium signaling modulation as a key regulatory target for apoptosis research.

• Polybrene (Hexadimethrine Bromide): Precision in Viral Trans

  2026-06-14

  Explore how Polybrene (Hexadimethrine Bromide) enables precision viral transduction and advanced assay optimization. This guide reveals molecular mechanisms, practical protocols, and new scientific insights for maximizing Polybrene’s impact in biomedical workflows.

• WZ4003: Redefining NUAK1/2 Inhibition in Human Brain Models

  2026-06-13

  Explore the unique capabilities of WZ4003, a selective NUAK1/2 inhibitor, in advanced human brain and cancer research. Discover how its mechanism and translational relevance set a new benchmark for disease modeling and assay design.

• Sodium Oxamate: Targeting Tumor Bioenergetics and Resistance

  2026-06-12

  Explore how Sodium Oxamate, a robust LDH-A inhibitor, empowers translational researchers to dissect and disrupt metabolic reprogramming in cancer—particularly in the context of radioresistance and lactate-driven DNA repair. This thought-leadership article integrates mechanistic insight, latest evidence, and strategic guidance for designing impactful tumor bioenergetics studies.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-06-12

  0.4% Trypan Blue Solution offers a direct, practical method for distinguishing live from dead cells in a variety of research workflows. It is best suited for cell viability measurement, cell counting, and cytotoxicity assays in cell culture systems—not for diagnostic or clinical applications.

• Rottlerin as a PKCδ Inhibitor: Precision Tools for Apoptosis

  2026-06-11

  Explore how Rottlerin, a selective PKC inhibitor, advances apoptosis research and cellular entry assays. This article provides a unique, in-depth analysis of Rottlerin’s molecular action and practical applications, highlighting insights not found in existing reviews.

• Targeting PCNA-POLD1 to Inhibit Pathologic Cardiac Hypertrop

  2026-06-11

  Pal et al. elucidate the central role of PCNA-POLD1–mediated DNA synthesis in driving cardiomyocyte endoreplication and pathological myocardial hypertrophy. Their work demonstrates that modulating the p21-PCNA-POLD1 axis can attenuate maladaptive cardiac growth, establishing a mechanistic foundation for new therapeutic strategies.

• Toxicology and Reversibility of Decitabine in Murine Models

  2026-06-10

  This study by Momparler and Frith provides a detailed toxicological profile of 5-Aza-2'-deoxycytidine (Decitabine) in mice, focusing on dose-limiting effects and tissue recovery dynamics. The findings inform preclinical safety assessments and dosing strategies for hematopoietic malignancy research.

• AM251: Advanced Modulation of CB1 Receptor Signaling in Neur

  2026-06-10

  Explore how AM251, a potent CB1 receptor antagonist, is reshaping cannabinoid receptor research and neuropharmacology. This in-depth analysis reveals unique mechanistic insights and practical assay applications that set AM251 apart in the field.

• Glycogen Colorimetric Assay Kit II: Reliable Glycogen Quanti

  2026-06-09

  This article explores real-world laboratory scenarios where the Glycogen Colorimetric Assay Kit II (SKU K2144) from APExBIO addresses persistent challenges in glycogen measurement. Grounded in evidence and recent literature, we analyze its workflow, reliability, and compatibility for metabolic and disease research, providing practical guidance for life science laboratories.

• Dual CDK4/6 and BET Inhibition Suppresses EMT in Pancreatic

  2026-06-09

  Gu et al. demonstrate that combined CDK4/6 and BET inhibition synergistically suppresses pancreatic ductal adenocarcinoma (PDAC) growth and epithelial-to-mesenchymal transition (EMT) by modulating the GSK3β-mediated Wnt/β-catenin pathway. This work highlights the mechanistic complexity of targeted therapies in PDAC and underscores the importance of pathway-crosstalk in designing anti-metastatic strategies.

• Potassium Iodide in Research: Optimizing Thyroid & Immunothe

  2026-06-08

  Harnessing Potassium Iodide (KI) from APExBIO enables precision in thyroid modulation and cutting-edge immunotherapy workflows. Explore robust experimental protocols, troubleshooting insights, and the translational bridge between endocrinology and tumor microenvironment research.

• BI 2536: PLK1 Inhibitor Protocols and Troubleshooting in Can

  2026-06-08

  BI 2536 stands out as a gold-standard PLK1 inhibitor, empowering researchers to dissect mitotic regulation and apoptosis in cancer models. This guide translates current best practices and recent methodological advances into actionable workflows, troubleshooting insights, and strategic comparisons for optimized use of BI 2536 in both in vitro and in vivo studies.

• QX77: Precision Modulation of Chaperone-Mediated Autophagy P

  2026-06-07

  Explore how QX77, a molecular chaperone activator, uniquely advances chaperone-mediated autophagy research by targeting LAMP2A and Rab11. This in-depth analysis reveals novel insights and practical protocols for stem cell and autophagy pathway studies.

• α7nAChR-Mediated Endothelial Pyroptosis in HIV-1 gp120 BBB I

  2026-06-06

  This study uncovers a previously unrecognized pathway by which HIV-1 gp120 compromises blood–brain barrier (BBB) integrity through α7 nicotinic acetylcholine receptor (α7nAChR)-driven pyroptosis in brain endothelial cells. The findings redefine the pathogenic role of α7nAChR in HIV-associated neurocognitive disorder (HAND) and highlight a clinically actionable therapeutic strategy using memantine and metformin.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page